The Latest Cardiac and Vascular News
– Strong preclinical data shows that C21 reverses vascular remodelling – Proof-of-concept trial in pulmonary arterial hypertension (“PAH”) planned to start late 2022 – Appointment of two new senior clinical advisors in PAH GOTHENBURG, Sweden, March 9, 2022 /PRNewswire/ — Vicore Pharma Holding AB (publ) (“Vicore”), a clinical-stage pharmaceutical company developing medicines targeting […]
Advanced Cardiovascular Diagnostics Identifies Officers Who Needed Live-Saving Care ELIZABETH, N.J., March 9, 2022 /PRNewswire/ — On February 23rd and 24th, the Advanced Cardiovascular Diagnostic (ACD) Mobile Testing Unit performed cardio stress testing for the Police Officers of the Elizabeth, New Jersey Police Department. ACD tested approximately 60 members of their Department. During the examination period, the medical staff […]
Pioneer of IVL Selected as the Second Most Innovative Medical Device Company SANTA CLARA, Calif., March 08, 2022 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, has been named in Fast Company’s 2022 list of the World’s […]
Latest grant is the 9th awarded to Dascena from the National Institute of Health SAN FRANCISCO–(BUSINESS WIRE)–Dascena, a developer of machine learning diagnostic algorithms to enable early disease intervention and improved care outcomes for patients, has received a grant from the National Institute on Minority Health and Health Disparities (part of the National […]
Virtual-First Cardiology Company, Heartbeat Health, Achieves SOC 2® Security Control Compliance Certification, Reinforcing Its Commitment to Healthcare Data Security & Privacy. NEW YORK, March 07, 2022 (GLOBE NEWSWIRE) — Heartbeat Health, a Virtual-First Cardiology company that leverages data, device connectivity, and clinicians to deliver on-demand cardiovascular services, announced today that […]
– The breakthrough approval expands the existing indication of Jardiance® to include adults with heart failure with preserved ejection fraction (HFpEF), an underserved patient population that previously had no approved therapies in Europe – European marketing authorization follows the U.S. Food and Drug Administration (FDA)’s approval received on 24 February 2022 […]
S-CATH™ M is the only rapid-response, high-density esophageal temperature probe that is visible on 3D cardiac mapping systems. ENGLEWOOD, Colo., March 3, 2022 /PRNewswire/ — CIRCA Scientific, Inc. announced today that its S-CATH™ M Esophageal Temperature Probe is now cleared for sale in the United States. The new S-CATH M Probe can be […]
VALHALLA, N.Y., March 2, 2022 /PRNewswire/ — Retia Medical today announced that it received a Declaration of Compatibility from Philips for its Argos Cardiac Output Monitor to interface with Philips IntelliBridge system on the IntelliVue patient monitoring systems. The Argos Monitor is now a compatible and “supported device” for Philips IntelliVue Patient […]
DENVER and WASHINGTON, March 2, 2022 /PRNewswire/ — DispatchHealth, the nation’s first comprehensive in-home high acuity medical provider, today announced its collaboration with The American College of Cardiology (ACC), a nonprofit professional medical society, to enhance the lives of cardiovascular disease patients. The first of its kind, the collaboration between DispatchHealth and ACC is designed to […]
Cohort 4 to Enroll Patients with Non-Obstructive Hypertrophic Cardiomyopathy SOUTH SAN FRANCISCO, Calif., March 02, 2022 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the opening of enrollment in Cohort 4 of REDWOOD-HCM (Randomized Evaluation of Dosing With CK-274 in Obstructive Outflow Disease in HCM), an ongoing Phase 2 clinical trial of aficamten, an investigational next-generation cardiac […]
